Detalhe da pesquisa
1.
Fungal sugars boost vaccine protection.
Cell
; 185(4): 579-581, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35148839
2.
Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
Cell
; 184(13): 3467-3473.e11, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34133941
3.
Novel approaches for vaccine development.
Cell
; 184(6): 1589-1603, 2021 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740454
4.
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.
Cell
; 184(20): 5077-5081, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534444
5.
High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity.
Nat Immunol
; 24(6): 941-954, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37095378
6.
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
Cell
; 183(1): 169-184.e13, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931734
7.
A Thermostable mRNA Vaccine against COVID-19.
Cell
; 182(5): 1271-1283.e16, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32795413
8.
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.
Cell
; 182(3): 713-721.e9, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32778225
9.
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
Nat Immunol
; 23(6): 940-946, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35534723
10.
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
Nat Immunol
; 23(3): 360-370, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210622
11.
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.
Cell
; 178(6): 1313-1328.e13, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31491384
12.
Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques.
Nat Immunol
; 22(12): 1515-1523, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34811542
13.
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination.
Nat Immunol
; 22(10): 1294-1305, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34556879
14.
Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies.
Immunity
; 54(12): 2859-2876.e7, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34788599
15.
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
Immunity
; 53(4): 724-732.e7, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783919
16.
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike.
Nature
; 624(7992): 639-644, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871613
17.
1st International Conference on Human &Translational Immunology.
Nat Immunol
; 18(1): 1-4, 2016 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27984565
18.
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity.
Nature
; 601(7894): 617-622, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34814158
19.
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.
Nature
; 601(7893): 410-414, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794169
20.
Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults.
N Engl J Med
; 388(7): 609-620, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791161